Metabolic and Reproductive Profile of Participating Women With and Without PCOS
Clinical Features . | Sample Size (n) . | Without PCOS [Mean ± SD or Median (IQR)] . | With PCOS [Mean ± SD or Median (IQR)] . | P . |
---|---|---|---|---|
Lipid profile | ||||
Cholesterol, mmol/L | 30 | 4.2 ± 0.7 | 4.4 ± 0.7 | 0.5 |
Triglycerides, mmol/L | 30 | 0.6 (0.6, 0.9) | 0.8 (0.5, 1.0) | 0.6 |
HDL, mmol/L | 30 | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.0 |
LDL, mmol/L | 30 | 2.5 ± 0.6 | 2.4 ± 0.7 | 0.6 |
OGTT | ||||
Fasting glucose, mmol/L | 34 | 4.9 (4.8, 5.4) | 4.9 (4.6, 5.3) | 0.4 |
Fasting insulin, pmol/L | 34 | 72.8 (56.2, 89.4) | 68.5 (47.2, 102.4) | 0.9 |
2-h Glucose, mmol/L | 34 | 4.75 (4.5, 5.4) | 5.5 (4.6, 5.8) | 0.2 |
2-h Insulin, pmol/L | 34 | 278 (207, 399) | 309 (165, 737) | 0.5 |
AUC glucose, mmol/L | 33 | 665.8 ± 75.4 | 783.7 ± 167.8 | 0.02 |
AUC insulin, mmol/L | 33 | 48,012 ± 18,367 | 66,180 ± 40,350 | 0.11 |
HOMA | 34 | 2.65 (2.0, 3.2) | 2.41 (1.7, 4.4) | 0.9 |
Reproductive markers | ||||
fT, pM | 34 | 23.2 (17.7, 31.2) | 10.80 (10.3, 14.1) | <0.001 |
SHBG, nmol/L | 34 | 62.1 ± 21.5 | 63.4 ± 38.4 | 0.9 |
FAI | 34 | 1.42 (1.4, 2.2) | 3.17 (2.2, 5.3) | <0.001 |
AMH, pmol/L | 33 | 18.9 (10.8, 31.1) | 48.6 (37.7, 74.6) | <0.001 |
Systemic methyl substrate/donors | ||||
SAM, µg/mL | 32 | 7.7 (5.4, 8.3) | 6.9 (6.0, 12.8) | 0.7 |
Folate, nmol/L | 33 | 29.9 (23.2, 37.5) | 37.3 (23.4, 45.8) | 0.08 |
Homocysteine | 33 | 9.0 (6.9, 10.1) | 7.1 (6.4, 9.7) | 0.3 |
Cytokines | ||||
HsCRP, mg/L | 30 | 1.3 (0.5, 3.3) | 1.4 (0.6, 4.5) | 0.7 |
IL-6, pg/ml | 31 | 1.8 (1.3, 3.0) | 2.1 (1.5, 2.9) | 0.3 |
Cell counts | ||||
WBC, µL | 31 | 5335 ± 1229 | 5750 ± 1497 | 0.4 |
Clinical Features . | Sample Size (n) . | Without PCOS [Mean ± SD or Median (IQR)] . | With PCOS [Mean ± SD or Median (IQR)] . | P . |
---|---|---|---|---|
Lipid profile | ||||
Cholesterol, mmol/L | 30 | 4.2 ± 0.7 | 4.4 ± 0.7 | 0.5 |
Triglycerides, mmol/L | 30 | 0.6 (0.6, 0.9) | 0.8 (0.5, 1.0) | 0.6 |
HDL, mmol/L | 30 | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.0 |
LDL, mmol/L | 30 | 2.5 ± 0.6 | 2.4 ± 0.7 | 0.6 |
OGTT | ||||
Fasting glucose, mmol/L | 34 | 4.9 (4.8, 5.4) | 4.9 (4.6, 5.3) | 0.4 |
Fasting insulin, pmol/L | 34 | 72.8 (56.2, 89.4) | 68.5 (47.2, 102.4) | 0.9 |
2-h Glucose, mmol/L | 34 | 4.75 (4.5, 5.4) | 5.5 (4.6, 5.8) | 0.2 |
2-h Insulin, pmol/L | 34 | 278 (207, 399) | 309 (165, 737) | 0.5 |
AUC glucose, mmol/L | 33 | 665.8 ± 75.4 | 783.7 ± 167.8 | 0.02 |
AUC insulin, mmol/L | 33 | 48,012 ± 18,367 | 66,180 ± 40,350 | 0.11 |
HOMA | 34 | 2.65 (2.0, 3.2) | 2.41 (1.7, 4.4) | 0.9 |
Reproductive markers | ||||
fT, pM | 34 | 23.2 (17.7, 31.2) | 10.80 (10.3, 14.1) | <0.001 |
SHBG, nmol/L | 34 | 62.1 ± 21.5 | 63.4 ± 38.4 | 0.9 |
FAI | 34 | 1.42 (1.4, 2.2) | 3.17 (2.2, 5.3) | <0.001 |
AMH, pmol/L | 33 | 18.9 (10.8, 31.1) | 48.6 (37.7, 74.6) | <0.001 |
Systemic methyl substrate/donors | ||||
SAM, µg/mL | 32 | 7.7 (5.4, 8.3) | 6.9 (6.0, 12.8) | 0.7 |
Folate, nmol/L | 33 | 29.9 (23.2, 37.5) | 37.3 (23.4, 45.8) | 0.08 |
Homocysteine | 33 | 9.0 (6.9, 10.1) | 7.1 (6.4, 9.7) | 0.3 |
Cytokines | ||||
HsCRP, mg/L | 30 | 1.3 (0.5, 3.3) | 1.4 (0.6, 4.5) | 0.7 |
IL-6, pg/ml | 31 | 1.8 (1.3, 3.0) | 2.1 (1.5, 2.9) | 0.3 |
Cell counts | ||||
WBC, µL | 31 | 5335 ± 1229 | 5750 ± 1497 | 0.4 |
Abbreviations: AUC, area under the curve; HDL, high-density lipoprotein; HOMA, homeostatic model assessment; HsCRP, high-sensitivity C-reactive protein; FAI, Free Androgen Index; IQR, interquartile range; LDL, low-density lipoprotein; WBC, white blood cell.
Metabolic and Reproductive Profile of Participating Women With and Without PCOS
Clinical Features . | Sample Size (n) . | Without PCOS [Mean ± SD or Median (IQR)] . | With PCOS [Mean ± SD or Median (IQR)] . | P . |
---|---|---|---|---|
Lipid profile | ||||
Cholesterol, mmol/L | 30 | 4.2 ± 0.7 | 4.4 ± 0.7 | 0.5 |
Triglycerides, mmol/L | 30 | 0.6 (0.6, 0.9) | 0.8 (0.5, 1.0) | 0.6 |
HDL, mmol/L | 30 | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.0 |
LDL, mmol/L | 30 | 2.5 ± 0.6 | 2.4 ± 0.7 | 0.6 |
OGTT | ||||
Fasting glucose, mmol/L | 34 | 4.9 (4.8, 5.4) | 4.9 (4.6, 5.3) | 0.4 |
Fasting insulin, pmol/L | 34 | 72.8 (56.2, 89.4) | 68.5 (47.2, 102.4) | 0.9 |
2-h Glucose, mmol/L | 34 | 4.75 (4.5, 5.4) | 5.5 (4.6, 5.8) | 0.2 |
2-h Insulin, pmol/L | 34 | 278 (207, 399) | 309 (165, 737) | 0.5 |
AUC glucose, mmol/L | 33 | 665.8 ± 75.4 | 783.7 ± 167.8 | 0.02 |
AUC insulin, mmol/L | 33 | 48,012 ± 18,367 | 66,180 ± 40,350 | 0.11 |
HOMA | 34 | 2.65 (2.0, 3.2) | 2.41 (1.7, 4.4) | 0.9 |
Reproductive markers | ||||
fT, pM | 34 | 23.2 (17.7, 31.2) | 10.80 (10.3, 14.1) | <0.001 |
SHBG, nmol/L | 34 | 62.1 ± 21.5 | 63.4 ± 38.4 | 0.9 |
FAI | 34 | 1.42 (1.4, 2.2) | 3.17 (2.2, 5.3) | <0.001 |
AMH, pmol/L | 33 | 18.9 (10.8, 31.1) | 48.6 (37.7, 74.6) | <0.001 |
Systemic methyl substrate/donors | ||||
SAM, µg/mL | 32 | 7.7 (5.4, 8.3) | 6.9 (6.0, 12.8) | 0.7 |
Folate, nmol/L | 33 | 29.9 (23.2, 37.5) | 37.3 (23.4, 45.8) | 0.08 |
Homocysteine | 33 | 9.0 (6.9, 10.1) | 7.1 (6.4, 9.7) | 0.3 |
Cytokines | ||||
HsCRP, mg/L | 30 | 1.3 (0.5, 3.3) | 1.4 (0.6, 4.5) | 0.7 |
IL-6, pg/ml | 31 | 1.8 (1.3, 3.0) | 2.1 (1.5, 2.9) | 0.3 |
Cell counts | ||||
WBC, µL | 31 | 5335 ± 1229 | 5750 ± 1497 | 0.4 |
Clinical Features . | Sample Size (n) . | Without PCOS [Mean ± SD or Median (IQR)] . | With PCOS [Mean ± SD or Median (IQR)] . | P . |
---|---|---|---|---|
Lipid profile | ||||
Cholesterol, mmol/L | 30 | 4.2 ± 0.7 | 4.4 ± 0.7 | 0.5 |
Triglycerides, mmol/L | 30 | 0.6 (0.6, 0.9) | 0.8 (0.5, 1.0) | 0.6 |
HDL, mmol/L | 30 | 1.5 ± 0.3 | 1.5 ± 0.3 | 1.0 |
LDL, mmol/L | 30 | 2.5 ± 0.6 | 2.4 ± 0.7 | 0.6 |
OGTT | ||||
Fasting glucose, mmol/L | 34 | 4.9 (4.8, 5.4) | 4.9 (4.6, 5.3) | 0.4 |
Fasting insulin, pmol/L | 34 | 72.8 (56.2, 89.4) | 68.5 (47.2, 102.4) | 0.9 |
2-h Glucose, mmol/L | 34 | 4.75 (4.5, 5.4) | 5.5 (4.6, 5.8) | 0.2 |
2-h Insulin, pmol/L | 34 | 278 (207, 399) | 309 (165, 737) | 0.5 |
AUC glucose, mmol/L | 33 | 665.8 ± 75.4 | 783.7 ± 167.8 | 0.02 |
AUC insulin, mmol/L | 33 | 48,012 ± 18,367 | 66,180 ± 40,350 | 0.11 |
HOMA | 34 | 2.65 (2.0, 3.2) | 2.41 (1.7, 4.4) | 0.9 |
Reproductive markers | ||||
fT, pM | 34 | 23.2 (17.7, 31.2) | 10.80 (10.3, 14.1) | <0.001 |
SHBG, nmol/L | 34 | 62.1 ± 21.5 | 63.4 ± 38.4 | 0.9 |
FAI | 34 | 1.42 (1.4, 2.2) | 3.17 (2.2, 5.3) | <0.001 |
AMH, pmol/L | 33 | 18.9 (10.8, 31.1) | 48.6 (37.7, 74.6) | <0.001 |
Systemic methyl substrate/donors | ||||
SAM, µg/mL | 32 | 7.7 (5.4, 8.3) | 6.9 (6.0, 12.8) | 0.7 |
Folate, nmol/L | 33 | 29.9 (23.2, 37.5) | 37.3 (23.4, 45.8) | 0.08 |
Homocysteine | 33 | 9.0 (6.9, 10.1) | 7.1 (6.4, 9.7) | 0.3 |
Cytokines | ||||
HsCRP, mg/L | 30 | 1.3 (0.5, 3.3) | 1.4 (0.6, 4.5) | 0.7 |
IL-6, pg/ml | 31 | 1.8 (1.3, 3.0) | 2.1 (1.5, 2.9) | 0.3 |
Cell counts | ||||
WBC, µL | 31 | 5335 ± 1229 | 5750 ± 1497 | 0.4 |
Abbreviations: AUC, area under the curve; HDL, high-density lipoprotein; HOMA, homeostatic model assessment; HsCRP, high-sensitivity C-reactive protein; FAI, Free Androgen Index; IQR, interquartile range; LDL, low-density lipoprotein; WBC, white blood cell.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.